Rohm & Hass is a Philadelphia-based chemical giant and a Fortune 500 company. Gupta was the point person in the negotiations between his company and chemical conglomerate Dow Chemical for the sale of Rohm & Hass.
The United States-based Rohm and Haas company, a speciality material major, is targeting a turnover of over $100 million from its Indian operations in the next five years.
Rohm and Haas, one of the largest speciality material manufacturers in the world, plans to invest $100 million (about Rs 410 crore) in India to develop manufacturing and research and development facilities.
The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.
Raj Gupta, former chairman and CEO of pharmaecuticals giant, Rohm & Haas, endowed $1 million fellowship to his alma mater, Cornell University in the name of his parents.
Leading IIT alumni in the United States, including former chairmen and CEOs of Fortune 500 multinational conglomerates like Raj L Gupta, expressed sadness over the Greek-like tragic fall of Rajat Gupta.
Dow Chemicals' acquisition of the Indian born billionnaire Raaj L Gupta headed speciality chemical company Rom and Haas for over $18 billion, is likely to impact its proposed joint venture with Reliance Industries (RIL) and expansion plans in India worth over $100 million.
Indian American, Raj L Gupta, chairman, president and CEO of Rohm and Haas Company has been chosen for the chemical industry's most prestigious honour - the 2007 Chemical Industry Medal, by the Society of Chemical Industry.
The India Abroad Person of the Year Awards, held at the National Museum of the American Indian in New York City on Friday June 12, honored 14 achievers in seven categories.
If the impact of the Greece crisis spreads across Europe and parts of the world which are more interconnected than ever before, India cannot hope to be insulated, says Paranjoy Guha Thakurta.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances